Viewing Study NCT03407651


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2026-01-25 @ 2:14 AM
Study NCT ID: NCT03407651
Status: COMPLETED
Last Update Posted: 2021-09-23
First Post: 2018-01-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Sponsor: Catalyst Biosciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A With Inhibitor View
None Hemophilia B With Inhibitor View
Keywords: